[fcb5af]: / literature / by_gene / RB1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34226971 10.1007/s00428-021-03148-9 2022 Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy. RB1
2 34551361 10.1016/j.jep.2021.114656 2022 Chinese patent medicine Aidi injection for cancer care: An overview of systematic reviews and meta-analyses. RB1
3 34657128 10.1038/s41375-021-01448-2 2022 Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. RB1
4 35609408 10.1016/j.lungcan.2022.05.002 2022 Neuroendocrine transformation from EGFR/ALK-wild type or TKI-naïve non-small cell lung cancer: An under-recognized phenomenon. RB1
5 35896160 10.1111/1759-7714.14592 2022 Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis. RB1
6 35982972 10.3389/fonc.2022.835965 2022 Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: <i>A Study of Six Cases</i>. RB1
7 32908255 10.1038/s41379-020-00669-7 2021 The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma. RB1
8 33541390 10.1186/s13039-020-00526-x 2021 Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis? RB1
9 33563892 10.1038/s41392-020-00412-3 2021 Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder. RB1
10 34232939 10.1097/CAD.0000000000001094 2021 Coexistence of a secondary STRN-ALK, EML4-ALK double-fusion variant in a lung adenocarcinoma patient with EGFR mutation: a case report. RB1
11 34340673 10.1186/s12885-021-08635-5 2021 Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia. RB1
12 34371436 10.1016/j.leukres.2021.106683 2021 Proposal and clinical application of molecular genetic risk scoring system, MRplus, for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre. RB1
13 34440292 10.3390/genes12081118 2021 T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness. RB1
14 34729013 10.2147/OTT.S323700 2021 <i>ALK</i> Rearrangement in Small-Cell Lung Cancer and Durable Response to Alectinib: A Case Report. RB1
15 31885322 10.1080/15384101.2019.1706903 2020 The double dealing of cyclin D1. RB1
16 31931161 10.1016/j.jep.2019.112536 2020 Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats. RB1
17 31992242 10.1186/s12887-020-1923-7 2020 Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma. RB1
18 32245383 10.1186/s12920-020-0709-y 2020 Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL. RB1
19 32345961 10.1038/s41408-020-0310-9 2020 DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma. RB1
20 32592278 10.1002/gcc.22882 2020 Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol. RB1
21 32661308 10.1038/s41598-020-68311-9 2020 MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia. RB1
22 33020271 10.1073/pnas.2007946117 2020 Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A. RB1
23 33324635 10.3389/fcell.2020.577784 2020 Dissection of Anti-tumor Activity of Histone Deacetylase Inhibitor SAHA in Nasopharyngeal Carcinoma Cells <i>via</i> Quantitative Phosphoproteomics. RB1
24 33369444 10.31557/APJCP.2020.21.12.3493 2020 Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis. RB1
25 30538135 10.1182/blood-2018-07-862151 2019 <i>CCND2</i> and <i>CCND3</i> hijack immunoglobulin light-chain enhancers in cyclin D1<sup>-</sup> mantle cell lymphoma. RB1
26 30563911 10.1101/gr.241141.118 2019 Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. RB1
27 30874617 10.1038/s41598-019-41078-4 2019 Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia. RB1
28 30926971 10.1038/s41588-019-0375-1 2019 Genomic subtyping and therapeutic targeting of acute erythroleukemia. RB1
29 30938769 10.1093/labmed/lmz008 2019 BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use. RB1
30 30988756 10.3892/etm.2019.7330 2019 Ginsenoside Rb1 protects cardiomyocytes from oxygen-glucose deprivation injuries by targeting microRNA-21. RB1
31 31112375 10.1111/ijlh.13052 2019 Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay. RB1
32 31202078 10.1016/j.leukres.2019.05.013 2019 Microarray testing as an efficient tool to redefine hyperdiploid paediatric B-cell precursor acute lymphoblastic leukaemia patients. RB1
33 31228652 10.1016/j.leukres.2019.05.009 2019 Prognostic gene alterations and clonal changes in childhood B-ALL. RB1
34 31411343 10.1002/path.5333 2019 Genomic characterisation of breast fibroepithelial lesions in an international cohort. RB1
35 29270859 10.1007/s12105-017-0876-0 2018 Sinonasal Leiomyosarcoma: Clinicopathological Analysis of Nine Cases with Emphasis on Common Association with Other Malignancies and Late Distant Metastasis. RB1
36 29407587 10.1016/j.leukres.2018.01.012 2018 High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction. RB1
37 29498923 10.1200/JCO.2017.74.3617 2018 IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. RB1
38 29575541 10.1111/ijlh.12805 2018 Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel. RB1
39 29636869 2018 Ginsenoside Rb1 inhibit apoptosis in rat model of Alzheimer's disease induced by Aβ<sub>1-40</sub>. RB1
40 30154667 10.2147/OTT.S172124 2018 <i>ALK</i>-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature. RB1
41 30203896 10.1002/gcc.22664 2018 Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases. RB1
42 30518749 10.1038/s41419-018-1212-7 2018 Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome. RB1
43 27339065 10.1080/10428194.2016.1193855 2017 Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia. RB1
44 27377594 10.1002/mc.22523 2017 Rb silencing mediated by the down-regulation of MeCP2 is involved in cell transformation induced by long-term exposure to hydroquinone. RB1
45 27979924 10.3324/haematol.2016.153023 2017 Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients. RB1
46 28089441 10.1016/j.clml.2016.12.001 2017 Prognostic Implications of Monosomies in Patients With Multiple Myeloma. RB1
47 28202519 10.1158/0008-5472.CAN-16-2571 2017 Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia. RB1
48 28281554 10.1038/modpathol.2017.3 2017 Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience. RB1
49 28285684 10.1016/j.lungcan.2017.02.005 2017 Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy? RB1
50 28401483 10.1007/s12032-017-0940-3 2017 Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients. RB1
51 28418845 10.18632/oncotarget.16216 2017 Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors. RB1
52 28439887 10.1111/bjh.14721 2017 Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts. RB1
53 28631637 10.4103/IJPM.IJPM_466_16 2017 An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemia. RB1
54 28674118 10.1158/1078-0432.CCR-17-0652 2017 Retinoblastoma and Neuroblastoma Predisposition and Surveillance. RB1
55 28886309 10.14715/cmb/2017.63.8.4 2017 The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia. RB1
56 26709271 10.3343/alm.2016.36.2.185 2016 B-cell Acute Lymphoblastic Leukemia With t(9;22)(q34;q11) Translocation and Clonal Divergence Through ider(22) Chromosome and t(13;17)(q14;q25) Translocation. RB1
57 26740820 10.1186/s13039-015-0212-x 2016 Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K). RB1
58 26781410 2016 [Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification]. RB1
59 27036041 10.18632/oncotarget.8414 2016 miR-590 promotes cell proliferation and invasion in T-cell acute lymphoblastic leukaemia by inhibiting RB1. RB1
60 27181063 10.1016/j.exphem.2016.04.011 2016 Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia. RB1
61 27235019 10.1016/j.jep.2016.05.055 2016 The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy. RB1
62 27399693 10.3390/ijms17071092 2016 miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells. RB1
63 27652204 10.21037/tlcr.2016.07.10 2016 Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors. RB1
64 27835869 10.18632/oncotarget.13181 2016 OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations. RB1
65 27889452 10.1016/j.molcel.2016.10.021 2016 An RB-EZH2 Complex Mediates Silencing of Repetitive DNA Sequences. RB1
66 27960642 10.1080/08880018.2016.1251518 2016 The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemia. RB1
67 28126143 10.1016/j.medcli.2016.07.035 2016 [Copy number alterations in adult patients with mature B acute lymphoblastic leukemia treated with specific immunochemotherapy]. RB1
68 25261097 10.3324/haematol.2014.112912 2015 Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia. RB1
69 25675863 10.1016/j.leukres.2015.01.008 2015 The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome. RB1
70 25676421 10.1038/leu.2015.41 2015 Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice. RB1
71 25706938 10.1002/gcc.22246 2015 A population-based single nucleotide polymorphism array analysis of genomic aberrations in younger adult acute lymphoblastic leukemia patients. RB1
72 26022239 10.1182/blood-2015-02-628792 2015 High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma. RB1
73 26027540 10.1016/j.clml.2015.03.018 2015 Genomic and Clinicopathologic Features of Primary Myelofibrosis With Isolated 13q Deletion. RB1
74 26205622 10.1111/bjh.13613 2015 Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia. RB1
75 26277549 10.1016/j.cancergen.2015.06.003 2015 Frequency of copy number abnormalities in common genes associated with B-cell precursor acute lymphoblastic leukemia cytogenetic subtypes in Brazilian children. RB1
76 26280220 10.1038/labinvest.2015.104 2015 Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma. RB1
77 26297264 10.1016/j.clml.2015.02.035 2015 Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia. RB1
78 26551667 10.1038/ng.3442 2015 The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. RB1
79 24166298 10.1038/leu.2013.317 2014 An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. RB1
80 24633422 10.1007/s00268-014-2485-3 2014 Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target. RB1
81 24678689 10.5858/arpa.2013-0101-RS 2014 Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review. RB1
82 24682267 10.1182/blood-2013-07-517177 2014 The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. RB1
83 24828667 10.1097/JTO.0000000000000142 2014 Small-cell lung cancers in patients who never smoked cigarettes. RB1
84 24913233 10.1084/jem.20132120 2014 Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. RB1
85 25126481 10.1089/biores.2014.0011 2014 Establishment and characterization of a singaporean chinese lung adenocarcinoma cell line with four copies of the epidermal growth factor receptor gene. RB1
86 25550786 2014 Epstein-Barr virus infection is inversely correlated with the expression of retinoblastoma protein in Reed-Sternberg cells in classic Hodgkin lymphoma. RB1
87 22812491 10.3109/10428194.2012.713481 2013 Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1. RB1
88 23334668 10.1038/ng.2532 2013 The genomic landscape of hypodiploid acute lymphoblastic leukemia. RB1
89 23483089 10.3343/alm.2013.33.2.130 2013 A rare case of transformation of childhood myelodysplastic syndrome to acute lymphoblastic leukemia. RB1
90 23508010 10.3324/haematol.2013.085175 2013 Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features. RB1
91 23676220 10.4161/cc.24928 2013 Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1. RB1
92 23900870 10.5114/pjp.2013.36199 2013 Allelic loss of selected tumor suppressor genes in acute lymphoblastic leukemia in children. RB1
93 23950931 10.1371/journal.pone.0070422 2013 RNAi mediated Tiam1 gene knockdown inhibits invasion of retinoblastoma. RB1
94 23961875 10.1111/bjh.12515 2013 Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma. RB1
95 23989127 10.1159/000351058 2013 Radiation therapy: retinal tumors. RB1
96 24189068 10.1074/jbc.M113.510669 2013 Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing. RB1
97 21693768 10.1093/annonc/mdr289 2012 Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion. RB1
98 22072402 10.1002/gcc.20944 2012 High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome. RB1
99 22834783 10.3109/09273948.2012.702843 2012 Genetics of primary intraocular tumors. RB1
100 22851563 10.1200/JCO.2011.40.3907 2012 IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. RB1